人机共生：脑机接口行业专家会议

Summary of Brain-Computer Interface Industry Conference Industry Overview - The brain-computer interface (BCI) technology is experiencing accelerated commercialization, with a patent growth rate significantly higher than that of academic papers. The global market size is expected to grow from $1.3 billion in 2020 to $10 billion by 2030, representing a compound annual growth rate (CAGR) of over 20% [1][4] - Non-invasive BCI technologies are expected to capture a larger market share due to shorter development cycles [1][4] Government Support - Governments worldwide are increasing support for BCI technology, with the U.S. launching a $5 billion Brain Initiative and various local governments in China providing funding support [1][5] Key Companies and Developments - Companies such as Kerlink, Precision Neuroscience, Lianchuang Co., and Medtronic are actively involved in both invasive and semi-invasive BCI fields. Kerlink's implantable platform has entered clinical trials, while Lianchuang Co. collaborates with Apple to control Vision Pro through BCI [1][5][6] - Medtronic combines spinal cord stimulation (SCS) therapy to help paralyzed patients regain mobility [1][6] Market Dynamics - The non-invasive BCI market is anticipated to dominate in the coming years due to its shorter development cycle, typically requiring 5 to 10 years for product development [1][4] - The development of artificial intelligence (AI) technology is expected to accelerate the decoding of brain waves, facilitating commercialization [1][8] Application Scenarios - BCI technology has broad applications in both medical and consumer sectors. Medical applications include disease treatment and functional replacement, while consumer applications involve brain state monitoring and human-computer interaction [3][10] - Non-invasive methods are likely to achieve large-scale implementation in areas such as attention training, emotional adjustment, and sleep assistance [3][10] Regulatory Environment - The National Medical Insurance Administration's policies aim to support the BCI industry, including cost guidelines for invasive and non-invasive procedures [16][17] - Current regulatory focus is on safety and efficacy, with strict clinical trials driving the development of medical devices [18] Challenges and Bottlenecks - The slow adoption of BCI technology is attributed to various factors, including the need for large-scale data collection and AI algorithm training to ensure device usability across different users [13] - Invasive BCI devices face longer development cycles and require extensive clinical trials before large-scale deployment [13] Future Outlook - The competitive landscape for invasive BCI products is expected to intensify over the next 3 to 5 years, with clinical trial results determining which companies can emerge as leaders [20] - Non-invasive devices are developing rapidly, with potential for significant market opportunities due to lower costs and quicker deployment compared to invasive options [20] Integration with Rehabilitation Robotics - The combination of BCI and rehabilitation robotics shows promising potential, particularly for stroke and other neurological patients. However, product design must be optimized for ease of use to facilitate independent operation by healthcare providers [21]